Systematic Reviews
Copyright ©The Author(s) 2022.
World J Clin Oncol. Oct 24, 2022; 13(10): 822-834
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.822
Table 6 Univariate and multivariate analysis outcomes for patients treated with radio-frequency ablation, radioembolization or solely chemotherapy
Ref.
Univariate analysis
Multivariate analysis
Tohme et al[29]High NLR associated with decreased OS P < 0.001High NLR associated with decreased OS (HR = 1.927, 95%CI: 1.202-3.089, P = 0.006)
Chang et al[26]Preoperative high NLR and postoperative increase in NLR were associated with decreased DFS (P = 0.044 and P = 0.022, respectively)Only postoperative NLR increase was associated with decreased DFS (P = 0.029)
Zhang et al[27]High NLR associated with decreased OS (P = 0.007) and DFS (P = 0.007)High NLR associated with decreased OS (P = 0.039, HR = 3.59, 95%CI: 1.54-9.67) and DFS (P = 0.022, HR = 3.19, 95%CI: 1.87-8.24).
Weiner et al[28]High NLR associated with decreased OS (HR = 2.18, 95%CI: 1.45-3.28, P = 0.0002)High NLR associated with decreased OS (HR = 2.22, 95%CI: 1.46-3.38, P = 0.0002)
Kishi et al[15]High NLR associated with decreased OS (HR = 3.1, 95%CI: 1.7-5.9, P < 0.001)High NLR associated with decreased OS (HR = 2.9, 95%CI: 1.5-5.5, P = 0.001).
Wu et al[31]High NLR (HR = 3.182, 95%CI: 1.277-7.933, P = 0.013) associated with decreased OS and DFS (HR = 2.284, 95%CI: 1.156-4.498, P = 0.017). Patients with normalization of NLR had better DFS than those with high NLR that did not decrease (P = 0.002).No association between NLR and survival
Philips et al[30]High NLR associated with decreased OS P = 0.067 (statistically significant)No association between NLR and survival